Apex Capital’s Pfizer PFE Stock Holding History

Apex Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-579,700	Closed	-$16.8M	–	67
2013 Q4	$16.8M	Buy	579,700 +52,700	+10%	+$1.53M	1.11%	34
2013 Q3	$14.4M	Buy	+527,000	New	+$14.3M	1.03%	46

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Apex Capital's PFE Position: Q1 2014 in Review

Apex Capital sold out of Pfizer (PFE) in Q1 2014, closing a stake of 579,700 shares — an estimated $16.8M sold.

Apex Capital first reported a position in PFE in Q3 2013 and held it in 2 quarters. The position peaked at $16.8M in Q4 2013. 1,781 funds tracked by Wall St. Rank hold PFE as of Q1 2014.

Apex Capital reported no remaining Pfizer position as of Q1 2014 after selling out during the quarter.
Apex Capital sold 579,700 Pfizer shares in Q1 2014, an estimated $16.8M.
Apex Capital first reported a position in Pfizer in Q3 2013 and held it in 2 quarters.
Apex Capital's Pfizer position peaked at $16.8M in Q4 2013.
1,781 funds tracked by Wall St. Rank held Pfizer as of Q1 2014.

Based on Apex Capital's 13F filing for Q1 2014, filed 12 May 2014.